EU Green Light In Sight For Aimovig; 12 Drugs In Line For Potential CHMP Decision

The European Medicines Agency's drug evaluation committee, the CHMP, will this week decide whether up to a dozen products that have been through the evaluation process should be recommended for approval in throughout the EU.

3d illustration of Man suffering migraine
New migraine prevention drug is moving closer to EU approval • Source: Shutterstock

More from Product Reviews

More from Pink Sheet